🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aims of this study are to compare the effectiveness of dexmedetomidine vers...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02
Trial ID
NCT07425444
Treatments Being Tested
Rationale: For the past 3 years the investigators have routinely used an ax...
Status
Completed
Location
Inova Fairfax Hospital
Start Date
2012-10
Trial ID
NCT01566838
Treatments Being Tested
The purpose of this study is to demonstrate the effectiveness of oral gluco...
Status
Unknown
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02645279
Treatments Being Tested
The purpose of this study is to determine if there is a difference in patie...
Status
Completed
Location
Hospital for Special Surgery, New York
Start Date
2017-01
Trial ID
NCT02996591
Treatments Being Tested
Thoracic procedures are routinely performed under general anesthesia (GA), ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-05-01
Trial ID
NCT03902470
Treatments Being Tested
The investigators believe that the local anesthetic EMLA (Lidocaine 2.5% an...
Status
Unknown
Location
Hillel Yaffe Medical Center
Start Date
2014-01
Trial ID
NCT02016976
Treatments Being Tested
A study to examine the effect of daridorexant on the way the body absorbs, ...
Status
Completed
Location
Nuvisan GmbH
Start Date
2022-08-23
Trial ID
NCT05480488
Treatments Being Tested
In this study, it was investigated whether the premedication drug administe...
Status
Unknown
Location
AbdurrahmanYAOTRH
Start Date
2022-10-16
Trial ID
NCT05647642
Treatments Being Tested
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested